Cytodyn Inc (CYDY)

[AaHh]

That’s why I’m afraid our S/C trial may be unsuccessuful, unless they can change the primary endpoint, which endpoint (mortality) even NP said is very difficult to achieve. I’m not any expert but I think we’ll have better success with the M/M phase 3.